Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MetCOVID: Methylprednisolone in Severe COVID-19
NCT04343729Phase 2Completed
- Sponsor
- Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
- Start
- Apr 2020
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone sodium succinate in coronavirus disease 2019 (COVID-19), sponsored by Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Started Apr 2020; status: completed.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04343729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04343729.